findmyKOL
Clinical trialNCT01302847CompletedPhase 1/PHASE2Interventional

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment181HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Dolutegravir (DTG) is an HIV drug in the integrase inhibitor drug class. This study evaluated the pharmacokinetics (PK), safety, tolerability of and immune response to DTG when used concurrently with optimized background therapy (OBT) in HIV-1 infected infants, children, and adolescents.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Botswana
  • Gaborone Crs (site Id: 12701)

    Gaborone, South-East District, Botswana

  • Molepolole Crs (site Id: 12702)

    Gaborone, Botswana

Brazil
  • Som Federal University Minas Gerais Brazil Nichd Crs (site Id: 5073)

    Belo Horizonte, Minas Gerais, Brazil

  • Hosp. Geral de Nova Igaucu Brazil Nichd Crs (site Id: 5097)

    Rio de Janeiro, Brazil

  • Hospital Federal Dos Servidores Do Estado Nichd Crs (site Id: 5072)

    Rio de Janeiro, Brazil

  • Instituto de Puericultura E Pediatria Martagao Gesteira - Ufrj Nichd Crs (site Id: 5071)

    Rio de Janeiro, Brazil

  • Univ. of Sao Paulo Brazil Nichd Crs (site Id: 5074)

    São Paulo, Brazil

Kenya
  • Kenya Medical Research Institute / Walter Reed Project Clinical Research Center, Kericho Crs (site Id: 5121)

    Kericho, Kenya

South Africa
  • Wits Rhi Shandukani Research Centre Crs (site Id: 8051)

    Johannesburg, Gauteng, South Africa

  • Umlazi Crs (site Id: 30300)

    Durban, KwaZulu-Natal, South Africa

  • Famcru Crs (site Id: 8950)

    Tygerberg, Western Cape, South Africa

Tanzania
  • Kilimanjaro Christian Medical Centre (kcmc) (site Id: 5118)

    Moshi, Tanzania

Thailand
  • Siriraj Hospital, Mahidol University Nichd Crs (site Id: 5115)

    Bangkok, Bangkoknoi, Thailand

  • Chiang Mai University Hiv Treatment (cmu Hiv Treatment) Crs (site Id: 31784)

    Chiang Mai, Thailand

  • Chiangrai Prachanukroh Hospital Nichd Crs (site Id: 5116)

    Chiang Mai, Thailand

United States
  • University of California, Uc San Diego Crs- Mother-Child-Adolescent Hiv Program (site Id: 4601)

    La Jolla, California, United States

  • Miller Children'S Hosp. Long Beach Ca Nichd Crs (site Id: 5093)

    Long Beach, California, United States

  • David Geffen School of Medicine at Ucla Nichd Crs (site Id: 5112)

    Los Angeles, California, United States

  • Univ. of California San Francisco Nichd Crs (site Id: 5091)

    San Francisco, California, United States

  • Univ. of Colorado Denver Nichd Crs (site Id: 5052)

    Aurora, Colorado, United States

  • Howard Univ. Washington Dc Nichd Crs (site Id: 5044)

    Washington D.C., District of Columbia, United States

  • South Florida Cdtc Ft Lauderdale Nichd Crs (site Id: 5055)

    Fort Lauderdale, Florida, United States

  • Usf - Tampa Nichd Crs (site Id: 5018)

    Tampa, Florida, United States

  • Lurie Children'S Hospital of Chicago (lch) Crs (site Id: 4001)

    Chicago, Illinois, United States

  • Rush Univ. Cook County Hosp. Chicago Nichd Crs (site Id: 5083)

    Chicago, Illinois, United States

  • Boston Medical Center Ped. Hiv Program Nichd Crs (site Id: 5011)

    Boston, Massachusetts, United States

  • Children'S Hosp. of Boston Nichd Crs (site Id: 5009)

    Boston, Massachusetts, United States

  • Metropolitan Hosp. Nichd Crs (site Id: 5003)

    New York, New York, United States

  • Bronx-Lebanon Hospital Center Nichd Crs (site Id: 5114)

    The Bronx, New York, United States

  • Jacobi Med. Ctr. Bronx Nichd Crs (site Id: 5013)

    The Bronx, New York, United States

  • Dumc Ped. Crs (site Id: 4701)

    Durham, North Carolina, United States

  • Seattle Children'S Research Institute Crs (site Id: 5017)

    Seattle, Washington, United States

Zimbabwe
  • Harare Family Care Crs (site Id: 31890)

    Harare, Zimbabwe

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DTG dispersible tabletsDTG film-coated tabletsDTG granules for suspension
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Apr 2011
Primary completion
20 Jan 2021
Completion
18 Oct 2023
Last update posted
12 Dec 2024
Registered enrollment
181
Registry id
NCT01302847

Cross-registrations

EU-CTR / CTIS (EudraCT)2010-020988-20

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.